Can innovation in endoscopic therapy alter clinical outcomes in patients with familial adenomatous polyposis?

CC BY-NC-ND 4.0 · Endosc Int Open 2021; 09(09): E1445-E1446
DOI: 10.1055/a-1521-4912

Editorial

Monique E. van Leerdam

¹Department of Gastroenterology and Gastro-intestinal Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands

²Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands

,

Andrew Latchford

³Polyposis Registry, St. Marks’s Hospital, Harrow, United Kingdom

⁴Department of Surgery and Cancer, Imperial College London, London, United Kingdom

References
1 Vasen HFA, Moslein G, Alonso A. et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 2008; 57: 707-713
2 Van Leerdam ME, Roos VH, van Hooft JE. et al. Endoscopic management of polyposis syndromes; European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2019; 51: 877-895
3 Monahan KJ, Bradshaw N, Dolwani S. et al. Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG). Gut 2020; 69: 411-444
4 Bulow S. Clinical features in familial polyposis coli. Results of the Danish Polyposis Register. Dis Colon Rectum 1986; 29: 102-107
5 Patel NJ, Ponugoti PL, Rex DK. Cold snare polypectomy effectively reduces polyp burden in familial adenomatous polyposis. Endosc Int Open 2016; 4: E472-E44
6 Pasquer A, Benech N, Pioche M. et al. Prophylactic colectomy and rectal preservation in FAP: systematic endoscopic follow up coupled with adenomas destruction may change the natural history of polyposis. Endosc Int Open 2021; 09: E1014-E1022